Details for New Drug Application (NDA): 084921
✉ Email this page to a colleague
NDA 084921 describes HYDROXOCOBALAMIN, which is a drug marketed by Abraxis Pharm, Actavis, and Watson Labs, and is included in three NDAs. It is available from one supplier. Additional details are available on the HYDROXOCOBALAMIN profile page.
The generic ingredient in HYDROXOCOBALAMIN is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
The generic ingredient in HYDROXOCOBALAMIN is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
Summary for 084921
| Tradename: | HYDROXOCOBALAMIN |
| Applicant: | Abraxis Pharm |
| Ingredient: | hydroxocobalamin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084921
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
